Loading...
Thumbnail Image
Publication

Caspase-11 promotes allergic airway inflammation.

Zasłona, Zbigniew
Flis, Ewelina
Wilk, Mieszko M
Carroll, Richard G
Palsson-McDermott, Eva M
Hughes, Mark M
Diskin, Ciana
Banahan, Kathy
Ryan, Dylan G
Hooftman, Alexander
... show 10 more
Alternative Titles
Publisher
Abstract
Activated caspase-1 and caspase-11 induce inflammatory cell death in a process termed pyroptosis. Here we show that Prostaglandin E2 (PGE2) inhibits caspase-11-dependent pyroptosis in murine and human macrophages. PGE2 suppreses caspase-11 expression in murine and human macrophages and in the airways of mice with allergic inflammation. Remarkably, caspase-11-deficient mice are strongly resistant to developing experimental allergic airway inflammation, where PGE2 is known to be protective. Expression of caspase-11 is elevated in the lung of wild type mice with allergic airway inflammation. Blocking PGE2 production with indomethacin enhances, whereas the prostaglandin E1 analog misoprostol inhibits lung caspase-11 expression. Finally, alveolar macrophages from asthma patients exhibit increased expression of caspase-4, a human homologue of caspase-11. Our findings identify PGE2 as a negative regulator of caspase-11-driven pyroptosis and implicate caspase-4/11 as a critical contributor to allergic airway inflammation, with implications for pathophysiology of asthma.
Language
en
Citation
ISSN
eISSN
2041-1723
ISBN
DOI
10.1038/s41467-020-14945-2
PMID
32103022
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval
Embedded videos